Article
Identification of potential biomarkers for aging diagnosis of mesenchymal stem cells derived from the aged donors
22 Mar 2024
Abstract excerpt
BACKGROUND: The clinical application of human bone-marrow derived mesenchymal stem cells (MSCs) for the treatment of refractory diseases has achieved remarkable results. However, there is a need for a systematic evaluation of the quality and safety of MSCs sourced from donors. In this study, we sought to assess one potential factor that might impact quality, namely the age of the donor. METHODS: We downloaded two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
